The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.
Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions
Open accessAbstract
BACKGROUND: Schizophrenia is among the major causes of disability worldwide and the mortality from cardiovascular disease (CVD) is significantly elevated. There is a growing concern that this health challenge is not fully understood and efficiently addressed. METHODS: Non-systematic review using searches in PubMed on relevant topics as well as selection of references based on the authors' experience from clinical work and research in the field. RESULTS: In most countries, the standardized mortality rate in schizophrenia is about 2.5, leading to a reduction in life expectancy between 15 and 20 years. A major contributor of the increased mortality is due to CVD, with CVD mortality ranging from 40 to 50% in most studies. Important causal factors are related to lifestyle, including poor diet, lack of physical activity, smoking, and substance abuse. Recent findings suggest that there are overlapping pathophysiology and genetics between schizophrenia and CVD-risk factors, further increasing the liability to CVD in schizophrenia. Many pharmacological agents used for treating psychotic disorders have side effects augmenting CVD risk. Although several CVD-risk factors can be effectively prevented and treated, the provision of somatic health services to people with schizophrenia seems inadequate. Further, there is a sparseness of studies investigating the effects of lifestyle interventions in schizophrenia, and there is little knowledge about effective programs targeting physical health in this population. DISCUSSION: The risk for CVD and CVD-related deaths in people with schizophrenia is increased, but the underlying mechanisms are not fully known. Coordinated interventions in different health care settings could probably reduce the risk. There is an urgent need to develop and implement effective programs to increase life expectancy in schizophrenia, and we argue that mental health workers should be more involved in this important task.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedWhat are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Kodama, S. (2009) · JAMA · doi:10.1001/jama.2009.681 · Cited by 3,035
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Alternative Dietary Indices Both Strongly Predict Risk of Chronic Disease
Chiuve, S. E., Fung, T. T., Rimm, E. B., Hu, F. B., McCullough, M. L., Wang, M., Stampfer, M. J., & Willett, W. C. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.157222 · Cited by 1,951
Blair, S. N. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540030039029 · Cited by 1,819
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Cigarette smoking among adults — United States, 1988
Bachman, J. G., Johnston, L. D., & OMalley, P. M. (1992) · Patient Education and Counseling · doi:10.1016/0738-3991(92)90149-d · Cited by 1,705
Cigarette Smoking Among Adults--United States, 2003
(2005) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.294.2.172 · Cited by 1,520
Optimal Diets for Prevention of Coronary Heart Disease
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.288.20.2569 · Cited by 1,503
Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422
Reward, dopamine and the control of food intake: implications for obesity
Volkow, N. D., Wang, G.-J., & Baler, R. D. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.001 · Cited by 1,400
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., Bucher, H. C., & Nordmann, A. J. (2013) · BMJ · doi:10.1136/bmj.f5934 · Cited by 1,351 · cited 1×
“Bariatric surgery, where parts of the digestive system are removed or bypassed, seems to provide greater weight reduction and higher rates of remission of type-2 diabetes and MetS compared to non-surgical interventions according to a recent meta-analysis limited to 2 years of follow-up (174).”
Ten Things that Motivational Interviewing Is Not
Miller, W. R., & Rollnick, S. (2009) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465809005128 · Cited by 1,315
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276 · cited 1×
“INCREASED CARDIORESPIRATORY FITNESS Patients with schizophrenia have low levels of physical activity (36).”
BackgroundAtypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Flier, J. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01081-x · Cited by 1,112
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
Blum, K., Braverman, E. R., Holder, J. M., Lubar, J. F., Monastra, V. J., Miller, D., Lubar, J. O., Chen, T. J. H., & Comings, D. E. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10736099 · Cited by 973
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951 · cited 3×
“Increasing the awareness of CVD-risk factors among psychiatrists and primary care physicians caring for patients with severe mental illness is also called for (190).”
BackgroundExcess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913 · cited 1×
“Today, the largest single cause of death in schizophrenia is cardiovascular disease (CVD) (2, 3), similar to the general population.”
BackgroundMueser, K. T., & McGurk, S. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16458-1 · Cited by 876
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Bueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & da Rocha Ataide, T. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513000548 · Cited by 778
Nordentoft, M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Laursen, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055176 · Cited by 778 · cited 1×
“Recently, mortality from natural causes was found to be especially high in patients with comorbid substance use disorders (49).”
BackgroundSize of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 2×
“1 for males and females, respectively (13).”
BackgroundComorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 675
Major physical and psychological harms of methamphetamine use
DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J. (2008) · Drug and Alcohol Review · doi:10.1080/09595230801923702 · Cited by 675
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
Osborn, D. P. J., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.242 · Cited by 608
Antipsychotic-induced weight gain: a review of the literature.
Allison, D. B., & Casey, D. E. (2001) · PubMed · Cited by 595
Motivational interviewing in health care settings Opportunities and limitations
Emmons, K. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00254-3 · Cited by 578
Motivational interviewing in health settings: a review
Britt, E., Hudson, S. M., & Blampied, N. M. (2004) · Patient Education and Counseling · doi:10.1016/s0738-3991(03)00141-1 · Cited by 575
Reward Processing in Schizophrenia: A Deficit in the Representation of Value
Gold, J. M., Waltz, J. A., Prentice, K. J., Morris, S. E., & Heerey, E. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn068 · Cited by 521
Life expectancy and cardiovascular mortality in persons with schizophrenia
Laursen, T. M., Munk-Olsen, T., & Vestergaard, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835035ca · Cited by 518
Public health importance of triggers of myocardial infarction: a comparative risk assessment
Nawrot, T. S., Perez, L., Künzli, N., Munters, E., & Nemery, B. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62296-9 · Cited by 518
Smoking and mental illness: results from population surveys in Australia and the United States
Lawrence, D., Mitrou, F., & Zubrick, S. R. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-285 · Cited by 517
From dopamine to salience to psychosis—Linking biology, pharmacology and phenomenology of psychosis
Kapur, S., Mizrahi, R., & Li, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.01.003 · Cited by 512
Andreassen, O. A., Djurovic, S., Thompson, W. K., Schork, A. J., Kendler, K. S., O’Donovan, M. C., Rujescu, D., Werge, T., van de Bunt, M., Morris, A. P., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.001 · Cited by 506
Self-citationOntogeny of taste preferences: basic biology and implications for health
Mennella, J. A. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.067694 · Cited by 443
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Comorbidity of Severe Psychotic Disorders With Measures of Substance Use
Hartz, S. M., Pato, C. N., Medeiros, H., Cavazos-Rehg, P., Sobell, J. L., Knowles, J. A., Bierut, L. J., & Pato, M. T. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3726 · Cited by 395
Obesity Among Those with Mental Disorders
Allison, D. B., Newcomer, J. W., Dunn, A. L., Blumenthal, J. A., Fabricatore, A. N., Daumit, G. L., Cope, M. B., Riley, W. T., Vreeland, B., Hibbeln, J. R., et al. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.11.020 · Cited by 394
The dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
(2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0219 · Cited by 383
The role of the insula in schizophrenia
Wylie, K. P., & Tregellas, J. R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.027 · Cited by 361
Lavie, C. J., Thomas, R. J., Squires, R. W., Allison, T. G., & Milani, R. V. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60548-x · Cited by 342
Blair, S. N. (1996) · JAMA · doi:10.1001/jama.276.3.205 · Cited by 334
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332
Mitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs082 · Cited by 327
Laursen, T. M., Wahlbeck, K., Hällgren, J., Westman, J., Ösby, U., Alinaghizadeh, H., Gissler, M., & Nordentoft, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067133 · Cited by 313
A systematic review of correlates of physical activity in patients with schizophrenia
Vancampfort, D., Knapen, J., Probst, M., Scheewe, T., Remans, S., & De Hert, M. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01814.x · Cited by 306
Interventions for smoking cessation and reduction in individuals with schizophrenia
Tsoi, D. T., Porwal, M., & Webster, A. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007253.pub3 · Cited by 304
Mondelli, V., Cattaneo, A., Murri, M. B., Di Forti, M., Handley, R., Hepgul, N., Miorelli, A., Navari, S., Papadopoulos, A. S., Aitchison, K. J., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06745 · Cited by 303
Exercise Therapy for Schizophrenia
Gorczynski, P., & Faulkner, G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq049 · Cited by 285
Antipsychotics and the Risk of Sudden Cardiac Death
Straus, S. M. J. M., Bleumink, G. S., Dieleman, J. P., van der Lei, J., ‘t Jong, G. W., Kingma, J. H., Sturkenboom, M. C. J. M., & Stricker, B. H. C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1293 · Cited by 260
EFFECTS OF EXERCISE ON MENTAL AND PHYSICAL HEALTH PARAMETERS OF PERSONS WITH SCHIZOPHRENIA
Beebe, L. H., Tian, L., Morris, N., Goodwin, A., Allen, S. S., & Kuldau, J. (2005) · Issues in Mental Health Nursing · doi:10.1080/01612840590959551 · Cited by 259
Bradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
Callaghan, R. C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Remington, G., & Gatley, J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.014 · Cited by 255 · cited 1×
“Tobaccorelated conditions comprised approximately 53% of total deaths in people with schizophrenia in a recent large cohort study (42).”
BackgroundMarital and Labor Market Status in the Long Run in Schizophrenia
Agerbo, E., Byrne, M., Eaton, W. W., & Mortensen, P. B. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.28 · Cited by 254
Validation of a physical activity assessment tool for individuals with schizophrenia
Faulkner, G., Cohn, T., & Remington, G. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.020 · Cited by 251
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial
Scheewe, T. W., Backx, F. J. G., Takken, T., Jörg, F., van Strater, A. C. P., Kroes, A. G., Kahn, R. S., & Cahn, W. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12029 · Cited by 246
Johansson, K., Neovius, M., & Hemmingsson, E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.070052 · Cited by 243
Dickerson, F., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., Schroeder, J., & Yolken, R. H. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200143 · Cited by 243
Maayan, L., Vakhrusheva, J., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.21 · Cited by 230
Metabolic Syndrome in Patients With Schizophrenia
Heiskanen, T., Niskanen, L., Lyytikäinen, R., Saarinen, P. I., & Hintikka, J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0513 · Cited by 228
Influence of antipsychotics on mortality in schizophrenia: systematic review
Weinmann, S., Read, J., & Aderhold, V. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.018 · Cited by 224
Interventions to reduce weight gain in schizophrenia
Faulkner, G., Cohn, T., & Remington, G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005148.pub2 · Cited by 222
The role of dietary fatty acids in the pathology of metabolic syndrome
Lottenberg, A. M., Afonso, M. D. S., Lavrador, M. S. F., Machado, R. M., & Nakandakare, E. R. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.03.004 · Cited by 220
Mizuno, Y., Suzuki, T., Nakagawa, A., Yoshida, K., Mimura, M., Fleischhacker, W. W., & Uchida, H. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu030 · Cited by 202
Menza, M., Vreeland, B., Minsky, S., Gara, M., Radler, D. R., & Sakowitz, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0404 · Cited by 201
An Update on the Role of Markers of Inflammation in Atherosclerosis
Corrado, E., Rizzo, M., Coppola, G., Fattouch, K., Novo, G., Marturana, I., Ferrara, F., & Novo, S. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2600 · Cited by 197
Exercise therapy for schizophrenia
Gorczynski, P. F., & Faulkner, G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004412.pub2 · Cited by 190
Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., Simonsen, C., Vaskinn, A., Birkeland, K. I., Friis, S., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0614 · Cited by 185
Self-citationReview: Mortality in schizophrenia: a measurable clinical endpoint
Bushe, C. J., Taylor, M., & Haukka, J. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382468 · Cited by 185
Mediterranean diet and metabolic syndrome: An updated systematic review
Esposito, K., Kastorini, C.-M., Panagiotakos, D. B., & Giugliano, D. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9253-9 · Cited by 182
Access to Medical Care Among Persons With Psychotic and Major Affective Disorders
Bradford, D. W., Kim, M. M., Braxton, L. E., Marx, C. E., Butterfield, M., & Elbogen, E. B. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.8.847 · Cited by 182
Physical health care of patients with schizophrenia in primary care: a comparative study
Roberts, L., Roalfe, A., Wilson, S., & Lester, H. (2006) · Family Practice · doi:10.1093/fampra/cml054 · Cited by 181
Health habits of patients with schizophrenia
Roick, C., Fritz-Wieacker, A., Matschinger, H., Heider, D., Schindler, J., Riedel-Heller, S., & Angermeyer, M. C. (2007) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-007-0164-5 · Cited by 180
Roberts, S. H., & Bailey, J. E. (2011) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05546.x · Cited by 174
Cancer mortality in patients with schizophrenia: An 11‐year prospective cohort study
Tran, E., Rouillon, F., Loze, J., Casadebaig, F., Philippe, A., Vitry, F., & Limosin, F. (2009) · Cancer · doi:10.1002/cncr.24383 · Cited by 173
Thioridazine and sudden unexplained death in psychiatric in-patients
Reilly, J. G., Ayis, S. A., Ferrier, I. N., Jones, S., & Thomas, S. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.6.515 · Cited by 173
Morrato, E. H., Newcomer, J. W., Kamat, S., Baser, O., Harnett, J., & Cuffel, B. (2009) · Diabetes Care · doi:10.2337/dc08-1720 · Cited by 171
Levensky, E. R., Forcehimes, A., O'Donohue, W. T., & Beitz, K. (2007) · AJN, American Journal of Nursing · doi:10.1097/01.naj.0000292202.06571.24 · Cited by 168
Use of General Medical Services Among Medicaid Patients With Severe and Persistent Mental Illness
Salsberry, P. J., Chipps, E., & Kennedy, C. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.4.458 · Cited by 167
Vestri, H. S., Maianu, L., Moellering, D. R., & Garvey, W. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301142 · Cited by 162
Effects of high aerobic intensity training in patients with schizophrenia—A controlled trial
Heggelund, J., Nilsberg, G. E., Hoff, J., Morken, G., & Helgerud, J. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.560278 · Cited by 156
Batel, P. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00203-0 · Cited by 150
Metabolic Syndrome and Depression
Heiskanen, T. H., NISKANEN, L. K., Hintikka, J., Koivumaa-Honkanen, H. T., Honkalampi, K. M., Haatainen, K. M., & Viinamäki, H. T. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0913 · Cited by 148
Motivational interviewing: a useful approach to improving cardiovascular health?
Thompson, D. R., Chair, S. Y., Chan, S. W., Astin, F., Davidson, P. M., & Ski, C. F. (2011) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2010.03558.x · Cited by 146
A 4-Fold Risk of Metabolic Syndrome in Patients With Schizophrenia
Saari, K. M., Lindeman, S. M., Viilo, K. M., Isohanni, M. K., Järvelin, M., Laurén, L., Savolainen, M. J., & Koponen, H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0503 · Cited by 146
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?
Leonard, B. E., Schwarz, M., & Myint, A.-M. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431622 · Cited by 141
Mitchell, A. J., Lord, O., & Malone, D. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.094532 · Cited by 141
Pérez‐Iglesias, R., Martínez‐García, O., Pardo‐García, G., Amado, J., García‐Unzueta, M. T., Tabarés‐Seisdedos, R., & Crespo‐Facorro, B. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001053 · Cited by 141
Engl, J., Rettenbacher, M., Fleischhacker, W. W., & Ebenbichler, C. F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301366 · Cited by 140
Delusions Are Associated With Poor Cognitive Insight in Schizophrenia
Engh, J. A., Friis, S., Birkenaes, A. B., Jónsdóttir, H., Klungsøyr, O., Ringen, P. A., Simonsen, C., Vaskinn, A., Opjordsmoen, S., & Andreassen, O. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn193 · Cited by 139
Self-citationDyslipidemia Independent of Body Mass in Antipsychotic-Treated Patients Under Real-Life Conditions
Birkenaes, A. B., Birkeland, K. I., Engh, J. A., Færden, A., Jónsdóttir, H., Ringen, P. A., Friis, S., Opjordsmoen, S., & Andreassen, O. A. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166c4f7 · Cited by 125
Self-citationPhentermine/Topiramate for the Treatment of Obesity
Smith, S. M., Meyer, M., & Trinkley, K. E. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r501 · Cited by 122 · cited 1×
“, lipase inhibitors (Orlistat), antidepressants (Lorcaserin, Bupropion), anticonvulsants (Topiramat), and also Metformin for the treatment of comorbid diabetes (162, 163).”
BackgroundPérez‐Iglesias, R., Crespo‐Facorro, B., Martínez‐García, O., Ramírez-Bonilla, M. L., Álvarez‐Jiménez, M., Pelayo‐Terán, J. M., García‐Unzueta, M. T., Amado, J., & Vázquez‐Barquero, J. L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.022 · Cited by 121
Hippisley‐Cox, J., Parker, C., Coupland, C. A. C., & Vinogradova, Y. (2007) · Heart · doi:10.1136/hrt.2006.110171 · Cited by 118
Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?
Wildgust, H. J., & Beary, M. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810384639 · Cited by 116
Vancampfort, D., Probst, M., Scheewe, T., Maurissen, K., Sweers, K., Knapen, J., & De Hert, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.018 · Cited by 113
Binder, M. D., Correll, C. U., & Cohen, D. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.029 · Cited by 112
Bridging the gap between mental and physical health: a multidisciplinary approach.
Vreeland, B. (2007) · PubMed · Cited by 110
Khan, A., Faucett, J., Morrison, S., & Brown, W. A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.149 · Cited by 109
Beebe, L. H., Smith, K., Burk, R., McIntyre, K., Dessieux, O. L., Tavakoli, A. S., Tennison, C., & Velligan, D. I. (2010) · Community Mental Health Journal · doi:10.1007/s10597-010-9363-8 · Cited by 109
Mitchell, A. J., & Lord, O. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382056 · Cited by 108
Potvin, S., & Marchand, S. (2007) · Pain · doi:10.1016/j.pain.2007.11.007 · Cited by 108
DSM-IV-TR?Mental Disorders: Diagnosis, Etiology and Treatment
First, M. B., & Tasman, A. (2004) · Medical Entomology and Zoology · Cited by 106
Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies
Harris, L. W., Guest, P. C., Wayland, M. T., Umrania, Y., Krishnamurthy, D., Rahmoune, H., & Bahn, S. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.009 · Cited by 99
Andreassen, O. A., McEvoy, L. K., Thompson, W. K., Wang, Y., Reppe, S., Schork, A. J., Zuber, V., Barrett-Connor, E. L., Gautvik, K. M., Aukrust, P., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02077 · Cited by 99
Self-citationEffects of smoking cannabis on lung function
Lee, M., & Hancox, R. J. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.40 · Cited by 98
Pain insensitivity in schizophrenia
Rosenthal, S. H., Porter, K. A., & Coffey, B. J. (1990) · General Hospital Psychiatry · doi:10.1016/0163-8343(90)90050-m · Cited by 95
Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation
Stunes, A. K., Reseland, J. E., Hauso, Ø., Kidd, M. S., Tømmerås, K. A., Waldum, H. L., Syversen, U., & Gustafsson, B. I. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01378.x · Cited by 92
Pain insensitivity in the relatives of schizophrenia patients
Hooley, J. M., & Delgado, M. L. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00064-5 · Cited by 90
Methapatara, W., & Srisurapanont, M. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02225.x · Cited by 88
Wang, J., & Li, M. D. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.178 · Cited by 88
A Test of the Cognitive Self-Medication Hypothesis of Tobacco Smoking in Schizophrenia
Hahn, B., Harvey, A. N., Concheiro, M., Huestis, M. A., Holcomb, H. H., & Gold, J. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.017 · Cited by 88
Mann, J. I. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00227.x · Cited by 87
Excess mortality among long-stay psychiatric patients in Northern Finland
Räsänen, S., Hakko, H. H., Viilo, K. M., Meyer‐Rochow, V. B., & Moring, J. (2003) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-003-0635-2 · Cited by 85
Kiviniemi, M., Suvisaari, J., Koivumaa-Honkanen, H. T., Häkkinen, U., Isohanni, M. K., & Hakko, H. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.043 · Cited by 84
Copeland, L. A., Zeber, J. E., Wang, C. P., Parchman, M. L., Lawrence, V. A., Valenstein, M. M., & Miller, A. L. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-127 · Cited by 84
Hahn, M., Chintoh, A. F., Giacca, A., Xu, L., Lam, L., Mann, S. W., Fletcher, P. J., Guenette, M. D., Cohn, T. A., Wolever, T., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.004 · Cited by 84
Mortality and Its Determinants in People With Psychotic Disorder
Suvisaari, J., Partti, K., Perälä, J., Viertiö, S., Saarni, S. E., Lönnqvist, J. K., Saarni, S. I., & Härkänen, T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31827ad512 · Cited by 81
Sudden deaths in psychiatric patients
Manu, P., Kane, J. M., & Correll, C. U. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06244gry · Cited by 80
A clinical study of the association of antipsychotics with hyperlipidemia
de León, J., Susce, M. T., Johnson, M., Hardin, M., Pointer, L., Ruaño, G., Windemuth, A., & Díaz, F. J. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.015 · Cited by 80
Occurrence of Painless Myocardial Infarction in Psychotic Patients
Marghand, W. E. (1955) · New England Journal of Medicine · doi:10.1056/nejm195507142530202 · Cited by 80
Beary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79
Moos, R. H., Brennan, P. L., & Mertens, J. R. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00902.x · Cited by 75
Schizophrenia guidelines across the world: A selective review and comparison
Gäebel, W., Riesbeck, M., & Wobrock, T. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.606801 · Cited by 74
BLOOD SUGAR STUDIES IN DEMENTIA PRAECOX AND MANIC-DEPRESSIVE INSANITY
Raphael, T. (1921) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1921.02180300052005 · Cited by 74
MORTALITY IN NORWEGIAN MENTAL HOSPITALS 1926–1941
Ødegård, Ø. (1951) · Human Heredity · doi:10.1159/000150667 · Cited by 73
Ringen, P. A., Melle, I. S., Birkenaes, A. B., Engh, J. A., Færden, A., Jónsdóttir, H., Nesvåg, R., Vaskinn, A., Friis, S., Larsen, F., et al. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01135.x · Cited by 71
Self-citationSmith, R. C., Lindenmayer, J., Bark, N. M., Warner‐Cohen, J., Vaidhyanathaswamy, S., & Khandat, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005110 · Cited by 71
Schwingshackl, L., & HOFFMANN, G. E. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514000464 · Cited by 70
Vik‐Mo, A. O., Birkenaes, A. B., Fernø, J., Jónsdóttir, H., Andreassen, O. A., & Steen, V. M. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008468 · Cited by 70
Self-citationDaumit, G. L., Dalcin, A., Jerome, G. J., Young, D. R., Charleston, J. B., Crum, R. M., Anthony, C. B., Hayes, J., McCarron, P. B., Khaykin, E., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.224 · Cited by 68
Dodd, K., Duffy, S., Stewart, J. A., Impey, J., & Taylor, N. F. (2010) · Disability and Rehabilitation · doi:10.3109/09638288.2010.526162 · Cited by 67
Chen, S., Broquères-You, D., Yang, G., Wang, Z., Li, Y., Wang, N., Zhang, X., Yang, F., & Tan, Y. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.08.056 · Cited by 67
Das, C., Mendez, G., Jagasia, S., & Labbate, L. A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400306 · Cited by 66
Ringen, P. A., Melle, I. S., Birkenaes, A. B., Engh, J. A., Færden, A., Vaskinn, A., Friis, S., Opjordsmoen, S., & Andreassen, O. A. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01244.x · Cited by 61
Self-citationRandomized double‐blind placebo‐controlled study of leptin administration after gastric bypass
Korner, J., Conroy, R., Febres, G., J. McMahon, D., Conwell, I., Karmally, W., & Aronne, L. J. (2013) · Obesity · doi:10.1002/oby.20433 · Cited by 60
Pain Insensitivity in Schizophrenic Patients
Bickerstaff, L. K. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400250059010 · Cited by 60
Metabolic Findings From the CATIE Trial and Their Relation to Tolerability
Nasrallah, H. A. (2006) · CNS Spectrums · doi:10.1017/s1092852900026663 · Cited by 59
Compton, M. T., Weiss, P., West, J. C., & Kaslow, N. J. (2005) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-005-0964-4 · Cited by 59
Multi-modal weight control intervention for people with persistent mental disorders.
Melamed, Y., Stein-Reisner, O., Gelkopf, M., Levi, G., Sivan, T., Ilievici, G., Rosenberg, R., Weizman, A., & Bleich, A. (2008) · Psychiatric Rehabilitation Journal · doi:10.2975/31.3.2008.194.200 · Cited by 58
Surgical Treatment of Morbid Obesity in Schizophrenic Patients
Hamoui, N., Kingsbury, S. J., Anthone, G. J., & Crookes, P. F. (2004) · Obesity Surgery · doi:10.1381/096089204322917873 · Cited by 57
Jin, H., Folsom, D. P., Sasaki, A., Mudaliar, S. R. D., Henry, R. R., Torres, M., Golshan, S., Glorioso, D., & Jeste, D. V. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.029 · Cited by 57
The Social Causes of Psychosis in North American Psychiatry: A Review of a Disappearing Literature
Jarvis, G. (2007) · Canadian journal of psychiatry. Revue canadienne de psychiatrie · doi:10.1177/070674370705200503 · Cited by 57
Smoking Reduction at Midlife and Lifetime Mortality Risk in Men: A Prospective Cohort Study
Gerber, Y., Myers, V., & Goldbourt, U. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr466 · Cited by 57
Faulkner, G., Gorczynski, P. F., & Cohn, T. A. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.4.538 · Cited by 55
Hart, C., Gruer, L. D., & Bauld, L. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt038 · Cited by 52
Schizophrenia: Medical Illness, Mortality, and Aging
Casey, D., Rodriguez, M. M., Northcott, C. J., Vickar, G. M., & Shihabuddin, L. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.41.3.c · Cited by 51
Crump, C., Ioannidis, J. P. A., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.034 · Cited by 51
Postmortem analysis of cardiovascular deaths in schizophrenia: A 10-year review
Sweeting, J., Duflou, J., & Semsarian, C. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.029 · Cited by 50
Behavioral therapy for weight loss in patients with schizophrenia.
Ganguli, R. (2007) · PubMed · Cited by 48
Receipt of Preventive Medical Services at Psychiatric Visits by Patients With Severe Mental Illness
Daumit, G. L., Crum, R. M., Güallar, E., & Ford, D. E. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.884 · Cited by 45
Gorczynski, P. F., Faulkner, G., Greening, S. G., & Cohn, T. A. (2010) · Psychiatric Rehabilitation Journal · doi:10.2975/34.1.2010.61.64 · Cited by 44
Dieset, I., Hope, S., Ueland, T., Bjella, T. D., Agartz, I., Melle, I. S., Aukrust, P., Røssberg, J. I., & Andreassen, O. A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.040 · Cited by 44
Self-citationAlcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders
Koola, M. M., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Warren, K. R., Feldman, S. M., Shim, J.-C., Love, R. C., & Kelly, D. L. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.04.019 · Cited by 43
Recognition of Co-Occurring Medical Conditions Among Patients With Serious Mental Illness
Kilbourne, A. M., McCarthy, J. F., Welsh, D. E., & Blow, F. C. (2006) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000230637.21821.ec · Cited by 41
Høye, A., Jacobsen, B. K., & Hansen, V. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.021 · Cited by 37 · cited 1×
“A particular cause for concern is that the mortality gap between the general population and schizophrenia seems to have increased during the last decades (8, 12).”
BackgroundChanges in weight in patients receiving a “tranquilizing” drug
Planansky, K. (1958) · Psychiatric Quarterly · doi:10.1007/bf01561635 · Cited by 36
Porsdal, V., Beal, C., Kleivenes, O. K., Martinsen, E. W., Lindström, E., Nilsson, H., & Svanborg, P. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-42 · Cited by 34
Burghardt, K. J., & Ellingrod, V. L. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0017-8 · Cited by 34
The impact of smoking cessation on schizophrenia and major depression
Ragg, M., Gordon, R., Ahmed, T., & Allan, J. (2013) · Australasian Psychiatry · doi:10.1177/1039856213486213 · Cited by 34
Lee, S. J., Ju, E. Y., Jun, C., & Kwon, J. S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0406 · Cited by 33
Base rates of physical activity in Australians with schizophrenia.
McLeod, H. J., Jaques, S., & Deane, F. P. (2009) · Psychiatric Rehabilitation Journal · doi:10.2975/32.4.2009.269.275 · Cited by 32
Birkenaes, A. B., Birkeland, K. I., Friis, S., Opjordsmoen, S., & Andreassen, O. A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819b95fc · Cited by 32
Self-citationTaylor, V. H., McKinnon, M. C., Macdonald, K., Jaswal, G., & MacQUEEN, G. M. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500605 · Cited by 30
Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders.
Miron, I., Baroană, V. C., Popescu, F., & Ionică, F. E. (2014) · PubMed Central · doi:10.12865/chsj.40.01.02 · Cited by 29
Saha, S., Whiteford, H., & McGrath, J. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413513341 · Cited by 28
Description of physical activity in outpatients with schizophrenia spectrum disorders
Beebe, L. H., & Harris, R. F. (2012) · International Journal of Mental Health Nursing · doi:10.1111/inm.12008 · Cited by 27
Smoking Cessation in People with Schizophrenia
Bennett, M. E., Wilson, A. E., Genderson, M., & Saperstein, A. M. (2014) · Current Drug Abuse Reviews · doi:10.2174/18744737112059990011 · Cited by 25
Pagels, P., Raustorp, A., Archer, T., Lidman, U., & Alricsson, M. (2012) · Journal of Physical Activity and Health · doi:10.1123/jpah.9.6.867 · Cited by 21
Tek, C., Gülöksüz, S., Srihari, V. H., & Reutenauer, E. L. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-176 · Cited by 21
Amrami-Weizman, A., Maayan, R., Gil‐Ad, I., Pashinian, A., Fuchs, C., Kotler, M., & Poyurovsky, M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3199-1 · Cited by 20
Vincenzi, B., Borba, C. P. C., Gray, D. A., Copeland, P. M., Wang, X., Fan, X., Aragam, G. G., & Henderson, D. C. (2013) · Annals of Clinical Psychiatry · doi:10.1177/104012371302500209 · Cited by 16
What can we do to reduce the burden of avoidable deaths in those with serious mental illness?
Crompton, D., Groves, A., & McGrath, J. J. (2010) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00001524 · Cited by 14
Petersen, L. V., & Sørensen, T. I. A. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810396560 · Cited by 13
Psychopharmacologic Treatment of Obesity and Eating Disorders in Children and Adolescents
Powers, P. S., & Cloak, N. L. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.003 · Cited by 10
Interventions for smoking cessation and reduction in individuals with schizophrenia
Tsoi, D. T.-Y., & Webster, A. C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007253 · Cited by 7
Cited by
Hjorthøj, C., Stürup, A. E., McGrath, J. J., & Nordentoft, M. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30078-0 · Cited by 1,304
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Cardiovascular disease in patients with severe mental illness
Nielsen, R. E., Banner, J., & Jensen, S. E. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00463-7 · Cited by 389
Blood-brain barrier regulation in psychiatric disorders
Kealy, J., Greene, C., & Campbell, M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.033 · Cited by 307
Metadata
- Authors
- Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2014-09-26
- Volume
- 5
- Pages
- 137-137
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2170987846
- Cited by
- 339
- References
- 192
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.